Prof. Eva Trevisson
Curriculum Vitae
Scopus ID: 8922220000
My research has focused on the study of the genetic bases and the pathogenesis of different genetic diseases, including inherited metabolic disorders (isolated cytochrome c oxidase defect, primary coenzyme Q deficiency) and urea cycle defects.
My group has set up different systems to validate pathogenic mutations and to establish genotype-phenotype correlations, using distinct approaches in both yeast and mammalian cells. To unravel the function of novel genes, I also employ multicellular organisms, including C. elegans and Zebrafish.
As a clinical geneticist, I am involved in cancer genetics and tumor predisposition syndromes. I am particularly interested in mechanisms driving cancers associated with a genetic predisposition (neurocutaneous disorders such as neurofibromatoses and schwannomatosis). I am employing the same organisms to model germline mutations in oncosuppressors/oncogenes identified in rare tumor predisposing syndromes in order to elucidate pathogenetic mechanisms and for drug screening.
I have co-authored 89 Medline peer-reviewed publications and 6 book chapters, with a total impact factor of 338 (Journal of Citation reports 2024), H-index 34 and total citations 4,102 (Scopus 2024).
I teach Molecular Genetics and Medical Genetics in different academic courses (including the Medical School and Medical biotechnologies), masters, medical residency programs and in the PhD program in Developmental Medicine and Programming Sciences at the University of Padova. I have supervised a number of undergraduate theses, more than 10 theses for residency programs and four PhD theses.
My research has focused on the study of the genetic bases and the pathogenesis of different genetic diseases, including inherited metabolic disorders (isolated cytochrome c oxidase defect, primary coenzyme Q deficiency) and urea cycle defects.
My group has set up different systems to validate pathogenic mutations and to establish genotype-phenotype correlations, using distinct approaches in both yeast and mammalian cells. To unravel the function of novel genes, I also employ multicellular organisms, including C. elegans and Zebrafish.
As a clinical geneticist, I am involved in cancer genetics and tumor predisposition syndromes. I am particularly interested in mechanisms driving cancers associated with a genetic predisposition (neurocutaneous disorders such as neurofibromatoses and schwannomatosis). I am employing the same organisms to model germline mutations in oncosuppressors/oncogenes identified in rare tumor predisposing syndromes in order to elucidate pathogenetic mechanisms and for drug screening.
I have co-authored 89 Medline peer-reviewed publications and 6 book chapters, with a total impact factor of 338 (Journal of Citation reports 2024), H-index 34 and total citations 4,102 (Scopus 2024).
I teach Molecular Genetics and Medical Genetics in different academic courses (including the Medical School and Medical biotechnologies), masters, medical residency programs and in the PhD program in Developmental Medicine and Programming Sciences at the University of Padova. I have supervised a number of undergraduate theses, more than 10 theses for residency programs and four PhD theses.